Navigation Links
Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
Date:4/21/2008

ort materials that provide best practices on patient selection, device implantation and patient discharge and follow-up to ensure optimal patient outcomes. In addition, we are implementing programs to educate referring cardiologists about the compelling data from our trial and to increase their understanding of and appreciation for the value of mechanical circulatory support available with the HeartMate II," Burbach continued.

"For a population having an unmet need and for which drug therapies have not proven to be an effective solution, we believe the HeartMate II represents a breakthrough therapy and new hope for these patients. It further demonstrates our leadership position in the mechanical circulatory support arena with the broadest portfolio of devices. We want to acknowledge the efforts of the clinicians and patients who participated in this landmark trial in making this day a reality," Burbach commented.

About HeartMate II

The HeartMate II is a mechanical circulatory support device intended for a broad range of advanced-stage heart failure patients. An axial flow device, the HeartMate II can pump up to 10 liters of blood per minute, the full output of a healthy heart, and is designed to provide long-term cardiac support. The device is implanted alongside a patient's native heart and takes over the pumping ability of the weakened heart's left ventricle. It is easier to implant than prior devices, and with only one moving part, the HeartMate II is designed to provide exceptional reliability and improved patient quality of life. The device is designed to have a much longer functional life than the previous generation of devices and to operate more simply and quietly.

About Thoratec

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate LVAS with more than 11,000 devices implanted in patients suffering fr
'/>"/>

SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
2. Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein
3. Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology
4. InterMune Announces Progress on Pirfenidone in IPF
5. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
6. Aida Announces New Anti-Cancer Drug Under Development
7. AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
8. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
9. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers
10. ViroPharma Announces Discontinuation of HCV-796 Development
11. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015  Check-Cap Ltd. (NASDAQ: CHEK ), ... development of a preparation-free ingestible imaging capsule that utilizes ... today that its CEO, Guy Neev , will ring ... day.  Neev and Check-Cap will participate in the closing ... public offering and simultaneous private placement which raised a ...
(Date:3/30/2015)... 2015 Perrigo Company plc (NYSE: PRGO ... Healthcare Products®," today announced that it has completed the ... a cash and equity transaction valued at approximately €3.8 ... debt. Sellers are Marc Coucke , Waterland Private ...   "The combination of Perrigo and ...
(Date:3/30/2015)... BOSTON , March 30, 2015  MedAptus® ... newest solution designed to simplify pre-care needs for ... rules-based intelligence to automatically assign patients to hospitalists ... continuity of care and other requirements such as ... efficiency. ...
Breaking Medicine Technology:Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 5MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 2MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 3
... LOVELAND, Colo., May 16, 2012   Heska Corporation (NASDAQ: ... veterinary diagnostic and other specialty veterinary products, today announced it ... Co. Investor Conference on Wednesday, May 23, 2012 at the ... D in Santa Monica, California.  The presentation is scheduled to ...
... SOUTH SAN FRANCISCO, Calif., May 16, 2012  Rigel Pharmaceuticals, ... respiratory franchise by focusing on two innovative, comprehensive treatment ... R343, an inhaled SYK inhibitor, will be entering a ... to moderate asthmatic patients. The other, R256, an inhaled ...
Cached Medicine Technology:Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 2Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 3Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 4
(Date:3/30/2015)... Textile Exchange, a global nonprofit dedicated to ... the latest version of its Responsible Down Standard ... be applied to any waterfowl-based supply chain to help ... product. The goal of the RDS is to recognize ... enable traceability so that products can be labeled accurately ...
(Date:3/30/2015)... “We are pleased to announce three ... May 30 in Los Angeles,” said Mark Wolper, Chair ... nominated from a nationwide call for nominations. , ... Mid-Atlantic, Richard Durden with LightHawk and Stephen Purello of ... award recipients will receive a $15,000 contribution from the ...
(Date:3/30/2015)... 2015 On March 11, 2015, Elle Magazine, ... Fat,” details six new treatment options for dealing with stubborn, ... is a topical product. The other three technologies use devices ... ) or freezing cold ( CoolSculpting ) to kill fat ... available to us to permanently remove unwanted fat," says Dr. ...
(Date:3/30/2015)... 30, 2015 Innovaacom, a leading provider ... today announced it is expanding its services into Asia ... area of the world comes at a time when ... demand for better healthcare. A rapidly growing aging population ... and advances in medicine in Asia. “We are excited ...
(Date:3/30/2015)... 2015 According to a recently published ... repair market will continue to dominate the European soft ... due to increasing numbers of ventral hernias, and the ... “The significantly large market share represented by ventral hernia ... We’re seeing a growing use of expensive biologics,” explains ...
Breaking Medicine News(10 mins):Health News:Responsible Down Standard 2.0 Released 2Health News:Responsible Down Standard 2.0 Released 3Health News:2015 Endeavor Awards Recipients Announced 2Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 3
... A new virus, a modified strain, has led to the ... Britain.// Five other pre mature babies are undergoing treatment. ... Norwich University Hospital after they were found to be carriers ... (S aureus). ,Hospital authorities have confirmed that the ...
... that identifies glucose levels. This sensor plays an important role ... increases or decreases the manufacture of glucose inside the human ... fat for the purpose of storage in adipose tissue. This ... it a potential site that can be targeted to treat ...
... in various hospitals in New York are having a nice ... ,The program is called Clown Care and believes in ... Apple Circus at New York-Presbyterian Hospital runs this program. It ... ago and was introduced by Michael Christensen, co-founder of Big ...
... Gym’ is due largely to the socializing that takes place ... not only for keeping fit and losing weight but also ... ,Nick Crossley, a Professor of Social Sciences from the University ... out the aspects motivating them to join health clubs. He ...
... certain stomach drugs may weaken the bones in the long ... new study that advises doctors to consider the risk when// ... of Pennsylvania Medical School studied records from the general practice ... over 50 and some had been taking proton pump inhibitors ...
... heavy investment opportunities for Non-Resident Keralites (NRK), making it ... term. ,Kerala Tourism Department has planned ... – 27 for showcasing the opportunities in the health ... congregation of major hospitals, health insurance companies, policy makers ...
Cached Medicine News:Health News:Glucose Sensor That Controls Glucose Metabolism Identified 2
... OMNI~NEB delivers breakthrough continuous low-flow nebulizer ... precise nozzle technology allows for optimal ... or without Heliox). OMNI~NEB takes on ... both routine and critical care situations. ...
... a spill-proof design and effective output, even ... All medical nebulizers are free-standing for easy ... are available., ,All Portex® medication nebulizer ... nebulizers feature consistently fine misting and the ...
... Eliminate the need for makeshift, modified nebulizer ... waste time gathering parts when your patient ... to deliver the utmost in Heliox rescue ... is fast becoming the standard of care ...
... Graham-Field has been developing diverse ... 58 years. Our medical-surgical products ... for innovation, quality and customer ... include the Labtron® line of ...
Medicine Products: